CADTH Canadian Drug Expert Committee final recommendation indication: asthma. Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.)
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health
2016.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820285306719 |
| Descripción Física: | 1 online resource (7 pages) |
|---|
